TrialInternational journal of hematology2026

Carfilzomib, pomalidomide, and dexamethasone for multiple myeloma after carfilzomib, lenalidomide, and dexamethasone.

Jun Ho Yi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.